Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec H | Hong Kong | Salute | Ricerca medica e biotecnologica | 144,45 Mrd HKD | 16x | -1,96 | 49,85 HKD | 20,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,8% Rialzo | Fai l’upgrade a Pro+ | |
Hansoh Pharmaceutical Group | Hong Kong | Salute | Prodotti farmaceutici | 119,05 Mrd HKD | 23,4x | 0,31 | 21,50 HKD | 7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,8% Rialzo | Fai l’upgrade a Pro+ | |
Innovent Biologics | Hong Kong | Salute | Prodotti farmaceutici | 77,07 Mrd HKD | -53,8x | -4,51 | 47,40 HKD | 5,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,6% Rialzo | Fai l’upgrade a Pro+ | |
Sino Biopharmaceutical | Hong Kong | Salute | Prodotti farmaceutici | 67,18 Mrd HKD | 15x | 0,2 | 3,69 HKD | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,5% Rialzo | Fai l’upgrade a Pro+ | |
CSPC Pharma | Hong Kong | Salute | Prodotti farmaceutici | 67,13 Mrd HKD | 10,4x | -3,98 | 5,76 HKD | 5,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 48,4% Rialzo | Fai l’upgrade a Pro+ | |
Sinopharm Group Co | Hong Kong | Salute | Prodotti farmaceutici | 63,04 Mrd HKD | 6,3x | -1,69 | 20,20 HKD | 7,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 34,2% Rialzo | Fai l’upgrade a Pro+ | |
Tigermed | Hong Kong | Salute | Ricerca medica e biotecnologica | 57,77 Mrd HKD | 44,7x | -0,73 | 34,50 HKD | 11,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,1% Rialzo | Fai l’upgrade a Pro+ | |
WuXi Biologics | Hong Kong | Salute | Ricerca medica e biotecnologica | 56,96 Mrd HKD | 19,2x | -0,51 | 15,92 HKD | 14,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 28,3% Rialzo | Fai l’upgrade a Pro+ | |
Akeso | Hong Kong | Salute | Ricerca medica e biotecnologica | 55,37 Mrd HKD | -53,5x | 0,51 | 68,25 HKD | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,2% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing Co Ltd | Hong Kong | Salute | Ricerca medica e biotecnologica | 50,42 Mrd HKD | 22,5x | 0,82 | 12,90 HKD | 14,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,3% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Pharma Holding | Hong Kong | Salute | Prodotti farmaceutici | 44,08 Mrd HKD | 17,9x | -1,47 | 11,92 HKD | 4,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
Shanghai Fosun Pharmaceutical | Hong Kong | Salute | Prodotti farmaceutici | 38,38 Mrd HKD | 36x | -0,53 | 14,42 HKD | 7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,4% Rialzo | Fai l’upgrade a Pro+ | |
Sichuan Kelun Biotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 37,73 Mrd HKD | -183,6x | -2,81 | 171 HKD | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
China Resources Pharma | Hong Kong | Salute | Prodotti farmaceutici | 35,24 Mrd HKD | 8,4x | -0,74 | 5,61 HKD | 4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29% Rialzo | Fai l’upgrade a Pro+ | |
Guangzhou Baiyunshan Pharma | Hong Kong | Salute | Prodotti farmaceutici | 31,67 Mrd HKD | 12x | -1,08 | 19,56 HKD | 5,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,6% Rialzo | Fai l’upgrade a Pro+ | |
Asymchem Laboratories Tianjin | Hong Kong | Salute | Prodotti farmaceutici | 29,86 Mrd HKD | 25x | -0,31 | 56,60 HKD | 13% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Genscript Biotech Corp | Hong Kong | Salute | Ricerca medica e biotecnologica | 28,05 Mrd HKD | -19,9x | -4,09 | 13,12 HKD | 16,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Livzon Pharma | Hong Kong | Salute | Prodotti farmaceutici | 26,31 Mrd HKD | 17,8x | -14,61 | 28,75 HKD | 7,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,1% Rialzo | Fai l’upgrade a Pro+ | |
WuXi XDC Cayman | Hong Kong | Salute | Prodotti farmaceutici | 24,50 Mrd HKD | 34,3x | 0,31 | 23,45 HKD | 14,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
HUTCHMED | Hong Kong | Salute | Prodotti farmaceutici | 24,43 Mrd HKD | -74,4x | 8,1 | 30,60 HKD | 8,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 43,1% Rialzo | Fai l’upgrade a Pro+ | |
Shandong Weigao Medical Polymer | Hong Kong | Salute | Attrezzature e forniture medicali | 23,72 Mrd HKD | 11x | -0,48 | 5,19 HKD | 3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 30,9% Rialzo | Fai l’upgrade a Pro+ | |
China Traditional Chinese Medicine | Hong Kong | Salute | Prodotti farmaceutici | 21,75 Mrd HKD | 21,4x | -16,76 | 4,32 HKD | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,9% Rialzo | Fai l’upgrade a Pro+ | |
China Medical System | Hong Kong | Salute | Prodotti farmaceutici | 20,81 Mrd HKD | 13,6x | -0,21 | 8,63 HKD | 6,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,1% Rialzo | Fai l’upgrade a Pro+ | |
United Laboratories Int | Hong Kong | Salute | Prodotti farmaceutici | 17,92 Mrd HKD | 5,6x | 0,16 | 9,83 HKD | 4,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22% Rialzo | Fai l’upgrade a Pro+ | |
Shenzhen Hepalink | Hong Kong | Salute | Prodotti farmaceutici | 17,12 Mrd HKD | -62,3x | 0,29 | 3,72 HKD | 2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,4% Rialzo | Fai l’upgrade a Pro+ | |
China Grand Pharma | Hong Kong | Salute | Prodotti farmaceutici | 17,12 Mrd HKD | 7,1x | 3,2 | 4,89 HKD | 4,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38% Rialzo | Fai l’upgrade a Pro+ | |
Simcere | Hong Kong | Salute | Prodotti farmaceutici | 15,93 Mrd HKD | -12,9x | 0,1 | 6,51 HKD | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31% Rialzo | Fai l’upgrade a Pro+ | |
Zai Lab | Hong Kong | Salute | Prodotti farmaceutici | 15,53 Mrd HKD | -6,3x | -0,29 | 17,80 HKD | 9,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
3SBio | Hong Kong | Salute | Prodotti farmaceutici | 15,26 Mrd HKD | 8,5x | -0,69 | 6,48 HKD | 6,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33,3% Rialzo | Fai l’upgrade a Pro+ | |
Ping An Healthcare Tech | Hong Kong | Salute | Fornitori e servizi sanitari | 14,43 Mrd HKD | -564,2x | -4,97 | 12,86 HKD | 6,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,6% Rialzo | Fai l’upgrade a Pro+ |